Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$167,204,752
-$38,704,399 QoQ
Shares Held
6,943,719
-5.3% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#71
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $1,469,110,886 across 10 Drug Manufacturers - General names. PFE ranks #5 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
357,284 | $428,537,182 | |
| 2 | JNJ |
Johnson & Johnson
|
1,192,228 | $302,790,144 | |
| 3 | ABBV |
AbbVie Inc.
|
680,811 | $171,319,279 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,305,364 | $167,739,274 | |
| 5 | PFE |
Pfizer Inc
This page
|
6,943,719 | $167,204,752 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,414,008 | $81,475,140 | |
| 7 | AMGN |
Amgen Inc
|
209,837 | $75,986,174 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
525,655 | $66,411,252 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,204,752 | 6,943,719 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $205,909,151 | 7,332,947 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $170,345,406 | 6,841,181 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $145,304,769 | 5,702,699 | Shares | Defined | 2025-12-02 | |
| 2025-06-30 | $141,299,735 | 5,829,197 | Shares | Defined | 2025-12-02 | |
| 2025-03-31 | $144,074,826 | 5,685,668 | Shares | Defined | 2025-12-02 | |
| 2024-12-31 | $147,550,175 | 5,561,635 | Shares | Sole | 2025-12-09 | |
| 2024-09-30 | $38,056,157 | 1,315,002 | Shares | Defined | 2025-12-09 | |
| 2024-06-30 | $38,924,180 | 1,391,143 | Shares | Sole | 2025-12-09 | |
| 2024-03-31 | $32,766,533 | 1,180,776 | Shares | Defined | 2025-12-09 | |
| 2023-12-31 | $33,957,689 | 1,179,496 | Shares | Sole | 2025-12-09 | |
| 2023-09-30 | $33,396,551 | 1,006,830 | Shares | Defined | 2025-12-09 | |
| 2023-06-30 | $37,511,975 | 1,022,682 | Shares | Sole | 2025-12-09 | |
| 2023-03-31 | $42,910,501 | 1,051,728 | Shares | Defined | 2025-12-09 | |
| 2022-12-31 | $56,319,932 | 1,099,140 | Shares | Defined | 2025-12-09 | |
| 2022-09-30 | $47,733,626 | 1,090,805 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $42,557,902 | 811,709 | Shares | Defined | 2025-12-09 | |
| 2022-03-31 | $50,582,861 | 977,069 | Shares | Defined | 2025-12-09 | |
| 2021-12-31 | $62,130,284 | 1,052,164 | Shares | Defined | 2025-12-29 | |
| 2021-09-30 | $44,239,095 | 1,028,577 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $44,060,952 | 1,125,152 | Shares | Sole | 2025-12-29 | |
| 2021-03-31 | $37,293,204 | 1,029,346 | Shares | Sole | 2025-12-29 | |
| 2020-12-31 | $39,414,528 | 1,070,756 | Shares | Defined | 2025-12-29 | |
| 2020-09-30 | $37,176,622 | 1,012,988 | Shares | Sole | 2025-12-29 | |
| 2020-06-30 | $42,708,761 | 1,306,077 | Shares | Sole | 2025-12-29 | |
| 2020-03-31 | $40,122,698 | 1,229,251 | Shares | Sole | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||